Effects of sleep medications on cognition, psychomotor skills, memory and driving performance in the elderly

Current Psychiatry Reviews

Volumn 3, Issue 4, 2007, Pages 281-292

  Verster, Joris C ^a   Volkerts, Edmund R ^a   Spence, D Warren ^b   Alford, Chris ^c   Pandi Perumal, Seithikurippu R ^d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Sleep and Neuropsychiatry Institute   (Canada)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition; Driving; Elderly; Falls; Hip fracture; Insomnia; Memory; Psychomotor

Indexed keywords

ALCOHOL; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROTIZOLAM; DIAZEPAM; ESTAZOLAM; ESZOPICLONE; FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC AGENT; LONG ACTING DRUG; LOPRAZOLAM; LORAZEPAM; LORMETAZEPAM; MELATONIN; MIDAZOLAM; MIRTAZAPINE; NITRAZEPAM; OXAZEPAM; PLACEBO; RAMELTEON; SECOBARBITAL; SHORT ACTING DRUG; TEMAZEPAM; TRAZODONE; TRIAZOLAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

AGING; ALERTNESS; AMNESIA; BEDTIME DOSAGE; BODY EQUILIBRIUM; CLINICAL TRIAL; COGNITION; COMORBIDITY; DAYTIME SOMNOLENCE; DOSE RESPONSE; DRIVING ABILITY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; FALLING; HIP FRACTURE; HUMAN; INSOMNIA; LEARNING; LONG TERM CARE; LONG TERM MEMORY; MEMORY; MEMORY DISORDER; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SHORT TERM MEMORY; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP DISORDER; TRAFFIC ACCIDENT; TREATMENT DURATION;

EID: 36249032045     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340007782408860     Document Type: Review

References (130)

1. Stewart RB, Marks RG, Padgett PD, et al. Benzodiazepine use in an ambulatory elderly population: a 14-year overview. Clin Ther 1994; 168: 118-124.
2. Walsh JK, Engelhardt CL. Trends in the pharmacological treatment of insomnia. J Clin Psychiat 1992; 53: 10-18.
3. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiat 1993; 42(3): 225-232.
4. Morgan K. Hypnotic drugs, psychomotor performance and ageing. J Sleep Res 1994; 3: 1-15.
5. Morin CM, Mimeault V, Gagné A. Nonpharmacological treatment of late-life insomnia. J Psychosomatic Res 1999; 46(2): 103-116.
6. Stewart R, Besset A, Bebbington P, et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16-74 years. Sleep 2006; 29(11): 1391-1397.
7. Jackson SHD. Dose optimalisation - the effect of age. Int Congress Series 2001; 1220: 259-271.
8. Ray WA, Griffith MR. Prescribed medications and the risk of falling. Top Geriatric Rehabil 1990; 5: 12-20.
9. Ray WA. Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 1992; 12: 386-96.
10. Cook PJ. Benzodiazepine hypnotics in the elderly. Acta Psych Scand 1986; 332: 149-158.
11. Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations, Part I. Clin Pharmacokinet 1991; 21: 165-171.
12. Kales A, Kales JD. Sleep disorders: recent findings in the diagnosis and treatment of disturbed sleep. N Eng J Med 1974; 290: 487-499.
13. Buysse DJ, Monk TH, Carrier J, Begley A. Circadian patterns of sleep, sleepiness, and performance in older and younger adults. Sleep 2005; 28(11): 1365-1376.
14. Ohayon MM, Vecchierini M-F. Daytime sleepiness and cognitive impairment in the elderly population. Arch Int Med 2002; 162: 201-208.
15. Ohayon MM, Vecchierini M-F. Normative sleep data, cognitive function and daily living activities in older adults in the community. Sleep 2005; 28(8): 981-989.
16. Thase ME. Correlates and consequences of chronic insomnia. General Hospital Psychiatry 2005; 27: 100-112.
17. Balter MB, Uhlenhuth EH. The beneficial and adverse effects of hypnotics. J Clin Psyehiatry 1991; 52(Suppl): 16-23.
18. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999; 22(Suppl 2): S354-S358.
19. Riedel BW, Lichstein KL. Insomnia and daytime functioning. Sleep Med Rev 2000; 4: 277-298.
20. Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 200 1; 5: 423-445.
21. Crenshaw MC, Edinger JD. Slow-wave sleep and waking cognitive performance among older adults with and without insomnia complaints. Physiol Behav 1999; 66: 485-492.
22. Bastien CH, Fortier-Brochu E, Rioux I, LeBlanc M, Daley M, Morin CM. Cognitive performance and sleep quality in the elderly suffering from chronic insomnia. Relationship between objective and subjective measures. J Psychosomatic Res 2003; 54: 39-49.
23. Jensen E, Dehlin O, Hagberg B, Samuelsson G, Svensson T. Insomnia in an 60-year-old population: Relationship to medical, psychological and social factors. J Sleep Res 1998; 7: 183-189.
24. Byles JE, Mishra GD, Harris MA. The experience of insomnia among older women. Sleep 2005; 28(8): 972-979.
25. Stelmach GE, Nahom A. Cognitive-motor abilities of the elderly driver. Hum Factors 1992; 34: 53-65.
26. Plude DJ, Hoyer WJ. Age and the selectivity of visual information processing. Psychol Aging 1986; 1: 4-10.
27. Madden DJ. Adult age differences in attention selectivity and capacity. Eur J Cogn Psychol 1990; 2: 229-252.
28. Harrison Y, Home JA, Rothwell A. Prefrontal neuropsychological effects of sleep deprivation in young adults - a model for healthy aging? Sleep 2000; 23(8): 1067-1073.
29. Madden DJ, Turkington TG, Provenzale JM, et al. Selective and divided visual attention: age-related changes in regional cerebral blood flow measured by H2150 PET. Hum Brain Map 1997; 5: 389-409.
30. Johnson CA, Keltner JL. Incidence of visual field loss in 20.000 eyes and its relationship to driving performance. Arch Ophthalmol 1983; 101: 371-375.
31. Keltner JL, Johnson CA. Visual function, driving safety, and the elderly. Ophthalmololgy 1987; 94: 1180-1188.
32. Owsley C, Ball K, Sloane ME, et al. Visual/cognitive correlates of vehicle accidents in older drivers. Psychol Aging 1991; 6: 403-415.
33. Ball K, Owsley C, Sloane ME, et al. Visual attention problems as a predictor of vehicle crashes in older drivers. Invest Ophthalmol Vis Sci 1993; 34: 3110-3123.
34. Grady CL. Brain imaging and age-related changes in cognition. Exp Gerontol 1998; 7/8: 661-673.
35. Grady CL, Maisog JM, Horwitz B, et al. Age-related changes in cortical blood flow activation during visual processing of faces and location. J Neurosci 1994; 14: 1450-1462.
36. Grady CL. Functional brain imaging and age-related changes in cognition. Biol Psychol 2000; 54: 259-281.
37. Foley DJ, Monjan A, Simonsick EM, et al. Incidence and remission of insomnia among elderly adults: an epidemiological study of 6800 pasons over three years. Sleep 1999; 22(Suppl 2): S366-S372.
38. McAndrews MP, Weiss RT, Sandor P, et al. Cognitive effects of long-term benzodiazepine use in older adults. Hum Psychopharmacol Clin Exp 2003; 18: 51-57.
39. Nilsson E, Fastbom J, Wahlin A. Cognitive functioning in a population-based sample of very old non-demented and non-depressed persons: the impact of diabetes. Arch Gerontol Geriatrics 2002; 35: 95-105.
40. Sanger DJ, Benavides J, Perrault G, et al. Rccent developments in the behavioral pharmacology of benzodiazepine (ω)) receptors: evidence for the functional significance of receptor subtypes. Neurosci Biobehav Rev 1994; 18: 355-372.
41. Doble A. New insights into the mechanisms of action hypnotics. J Psychopharmacol, 1999; 13(Suppl 4): S11-S20.
42. A receptors different from zolpidem, zopiclone and benzodiazepines. Neurosci Res Commun 1999; 25: 139-148.
43. A receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 2001; 22: 188-194.
44. Mamelak M, Csima A, Buck L, et al. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly. J Clin Psychopharmacol 1989; 9: 260-7.
45. Carskadon MA, Seidel WF, Greenblatt DJ, et al. Daytime carryover of triazolam and flurazepam in elderly insomniacs, Sleep 1982; 5: 361-71.
46. Dehlin O, Bjornson G. Triazolam as a hypnotic for geriatric patients. A double-blind cross-over comparison of nitrazepam and triazolam regarding effects on sleep and psychomotor performance. Acta Psychiatr Scand 1983; 67: 290-295.
47. Murphy P, Hindmarch I, Hyland CM. Aspects of short-term use of two benzodiazepine hypnotics in the elderly. Age Ageing 1982; 11: 222-228.
48. Cook PJ, Huggett A, Graham-Pole R, et al. Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. Br Med J 1983; 286 (6359): 100-102.
49. Morgan K. Effects of two benzodiazepines on the speed and accuracy of perceptual-motor performance in the elderly. Psychopharmacology 1984; 1(Suppl): 79-83.
50. Morgan K. Effects of repeated dose nitrazepam and lometazepam on psychomotor performance in the elderly. Psychopharmacology 1985; 86: 209-111.
51. Rettig HC, de Haan P, Zuurmond WW, et al. Effects of hypnotics on sleep and psychomotor performance. A double-blind randomized study of lometazepam, midazolam and zopiclone. Anaesthesia 1990; 45: 1079-1082.
52. Deijen JB, Heemstra ML, Orlebeke JF. Residual effects of lormatazepam on mood and performance in healthy elderly volunteers. Eur J Clin Pharmacol 1991, 40: 267-271.
53. Allain H, Benteu-Feffer D, Tarral A, et al. Effects of postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg pd lometazopam 2 mg in elderly healthy subjects. A randomized, cross-ever, doubled-blind study versus placebo. Eur J Clin Pharmacol 2003; 59: 179-188.
54. Vogel GW, Morris D. The effects of estazolam on sleep, performance and memory: a long-term sleep laboratory study of elderly insomniacs. J Clin Pharmacol 1992; 32: 647-51.
55. Briggs RS, Casdeden CM, Kraft CA. Improved hypnotic treatment using chlormethiazole and temazepam. Br Med J 1980; 280 (6214): 601-604.
56. Nakra BR, Gfeller JD, Hassan R. A double-blind comparison of the effects of temazepam and triazolam on residual daytime performance in elderly insomniacs. Int Psychogeriatr 1992; 4: 45-53.
57. Vgontzas AN, Kales A, Bixler EO, et al. Temazepam 7.5 mg: effects on sleep in elderly insomniacs. Eur J Clin Pharmacol 1994; 46: 209-213.
58. Hemmeter U, Muller M, Bischof R, et al. Effects of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacol 2000; 147: 384-396.
59. Glass JR, Sproule BA, Herrman N, et al. Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly volunteers. J Clin Psychopharmacol 2003; 23: 260-268.
60. Swift CG, Swift MR, Ankier SI, et al. Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. Br J Clin Pharmacol 1985; 20: 119-28.
61. Dorling MC, Hindmarch I. Pharmacokinetic profile of loprazolam in 12 young and 12 elderly healthy volunteers. Drugs Exp Clin Res 2001; 27: 151-9.
62. Bayer AJ, Pathy MS. Clinical and psychometric evaluation of two doses of loprazolam and placebo in geriatric patients. Curr Med Res Opin 1986; 10: 17-24.
63. Nikaido AM, Ellinwood EH, Heatherly DG, et al. Age-related increase in CNS sensitivity to benzodiazepines assessed by task difficulty. Psychopharmacol 1990; 101: 90-97.
64. Feldmeier C, Kapp W. Comparative clinical studies with midazolam, oxazepam and placebo. Br J Clin Pharmacol 1983; 16(Suppl 1): 15IS-155S.
65. Sonne J, Loft S, Dossing M, et al. Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects. Br J Clin Pharmacol 1991; 31: 719-722.
66. Angus WR, Romney DM. The effects of diazepam on patients' memory. J Clin Psychopharmacol 1984; 4: 203-206.
67. Pomara N, Stanley B, Block R, et al. Adverse effects of single therapeutic doses of diazepam on performance in normal geriatric subjects: relationship to plasma concentrations. Psychopharmacol 1984; 84: 342-346.
68. Pomara N, Stanley B, Block R, et al. Increased sensitivity of the elderly to the central depressant effects of diazepank. J Clin Psychiat 1985; 46: 185-187.
69. Hindmarch I. Alpidem and psychological performance in elderly subjects. Pharmacopsychiatry 1990; 23(suppl 3): 124-128.
70. Stazger W, Engel RR, Ferguson E, et al. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers. Pharmacopsychiat 1990; 23(Suppl 3): 114-119.
71. Pomara N, Tun H, DaSilva D, et al. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull 1998; 34: 139-153.
72. Kerr JS, Fairweather DB, Mahendran R, et al. The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly. Int Clin Psychopharmacol 1992; 7: 101-108.
73. Patat A, Albertini H, Bohomme D. et al. Effects of tiapride on electroencephalograms and cognitive functions in the elderly. Int Clin Psychopharmacol 1999; 14: 199-208.
74. Allain H, Tessier C, Bentué-Ferrer D, et al. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacol 2003; 165: 419-429.
75. Hart RP, Colenda CC, Hamer RM. Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects. Am J Psychiatry 1991; 148: 73-77.
76. Kaplan GB, Greenblatt DJ, Ehrenberg BL, et al. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects. J Clin Pharmacol 1998; 38: 14-21.
77. Kirpke DF. Chronic hypnotic use: deadly risks, doubtful benefit. Sleep Med Rev 2000; 4: 5-20.
78. Chen Y, Lader M. Long-term benzodiazepine treatment: is it ever justified? Hum Psychopharmacol 1990; 5: 301-312.
79. Seharf MB, Roth T, Vogel GW, et al. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiat 1994;. 55: 192-199.
80. Morin CM, Coleachi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia. JAMA 1999; 281: 991-999.
81. McCall W, D'Agostino R, Dunn A. A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. Sleep Med 2003; 4: 57-62.
82. Golombok S, Moodley P, Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988; 18: 365-374.
83. Golombok & Causes, effects and treatment of long-term benzodiazepine use: a review of psychological perspectives. Hum Psychopharmacol 1989; 4: 15-22.
84. Elby EM, Hogan DB, Fung TS. Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. J Clin Epidemiol 1997; 50: 857-863.
85. Vignola A, Lamoureaux C, Bastien CH, et al. Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults. J Gerontol Psychol Sci 2000; 55B: 54-62.
86. Kroboth PD, McAuley JW, Smith RB. Alprazolam in the elderly: pharmacokinetics and pharmacodynaamics dining multiple dosing. Psychopharmacology 1990; 100: 477-484.
87. Swift CG, Swift MR, Hampley J, Stevenson IH, Crooks J. Side-effect tolerance in elderly long-term recipients of benzodiazepine hypnotics. Age Ageing 1984; 13: 335-343.
88. Rummans TA, Davis LJ, Morse RM, et al. Learning and memory impairment in older, detoxified, benzodiazepine-dependent patients. Mayo Clin Proc 1993; 68: 731-737.
89. Salzman C, Fisher J, Novel K, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatir Psychiatry 1992; 7: 89-93.
90. Bonnett MH, Kramer M. The interaction of age performance and hypnotics in the sleep of insomniacs. J Am Geriatric Soc 1981; 29: 509-512.
91. Mamelak M, Csima A, Buck L, Price V. A comparative study on the effects of brotizalem and flurazepam on sleep and performance in the elderly. J Clin Psychopharmacol 1989; 9: 260-267.
92. Dehlin O, Rundgren A, Borjesson L, et al. Zopiclone to geriatric patients. A parallel double-blind dose-response clinical trial of zopiclone as a hypnotic to geriatric patients - a study in a geriatric hospital. Int Pharmacopsychiatry 1982; 17(Suppl 2): 173-178.
93. Dehlin O, Rundgren A, Borjesson L, et al. Zopiclone to geriatric patients. A parallel double-blind dose-response clinical trial of zopiclone as a hypnotic to geriatric patients - a study in a geriatric hospital. Pharmacology 1983; 27(Suppl 2): 173-178.
94. Scharf MB, Mayleben DW, Kaffeman M, et al. Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiat 1991; 52: 77-83.
95. Shaw SH, Curson H, Coquelin JP. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients. Int Med Res 1992; 20: 150-161.
96. Leger D, Scheuermaier K, Roger M. The relationship between alertness and sleep in a population of 769 elderly insomniacs with and without treatment with zolpidem. Arch Gerontol Geriatr 1999; 29: 165-173.
97. Fairweather DB, Kerr JS, Hindmarch I. The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol 1992; 43: 597-601.
98. Verster JC, Volkerts ER, Schreuder AHCML, et al. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions and psychomotor performance. J Clin Psychopharmacol 2002; 22: 576-583.
99. Hedner J, Yaeche R, Emilien G, et al. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. Int J Geriatr Psychiat 2000; 15: 704-712.
100. Marks R, Allegrante JP, McKenzie CR, et al. Hip fractures among the elderly: causes, consequences and control. Ageing Res Rev 2003; 2: 57-93.
101. Hayes WC, Myers ER, Robinovitch SN, et al. Etiology and prevention of age-related hip fractures. Bone 1996; 18: 77S-86S.
102. Lord SR, Anstey KJ, Williams,P, et al. Psychoactive medication use, sensori-motor function and falls in older women. Br J Clin Pharmacol 1995; 39: 227-234.
103. Neutel CI, Hirdes JP, Maxwell QJ, New evidence on benzodiazepine use and falls - the time factor. Age Ageing 1996; 25: 273-278.
104. Mendelson WB. The use of sedative/hypnotic medication and its correlation with falling down in the hospital. Sleep 1996; 19: 698-701.
105. Passaro A, Volpato S, Romagnoli F, et al. Benzodiazepines with different half-life and falling in a hospitalized population. The GIFA Study. J Clin Epidemiol 2000; 53: 1222-1229.
106. Ray, WA, Thapa PB, Gideon P. Benzodiazopines and the risks of falls in nursing home rosidents. J Am Geriatr Soc 2000; 48: 682-685.
107. Ray WA, Thapa PB, Gideon P. Misclassification of current benzodiazepine exposure by use of single baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol Drug Saf 2002; 11: 1-7.
108. Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf 2002; 11: 97-104.
109. Herings RM, Stricker BH, de Boor A, et al. Benzodiazepines and the risk of falling leading to femur fructures. Dosage more important than elimination half-life. Arch Int Med 1995; 155: 1801-1807.
110. Pierfitte C, Macouillard G, Thicoipe M, et al. Benzodiazepines and hip fiactures in elderly people: case-control study. BMJ 2001; 322: 704-708.
111. Wang PS, Bohn RL, Glynn RJ, et al. Zolpidem use and hip fractures in older people. J Am Gertiatr Soc 2001; 49: 1685-1690.
112. Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hipfracture. N Eng J Med 1987; 316: 363-369.
113. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262: 3303-3307.
114. Cumming RG, Klineberg RJ. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust 1993; 158: 414-417.
115. Retchin SM, Anapolle J. An overview of the older driver. Clin Geriatr Med 1993; 9: 279-296.
116. Marottoli RA, Mendes De Leon CF, Glass TA, et al. Driving cessation and increased depressive symptoms: prospective evidence from the New Haven EPESE. J Am Geriatr Soc 1997; 45: 202-206.
117. Bar R. Recent changes in driving among older adults. Hum Factors 1991; 33: 597-600.
118. Janke M. Accidents, mileage, and exaggeration of risk. Acci Anal Prev 1991; 23: 183-188.
119. Hakamies-Blomqvist L, Raitanen T, O'Neill D. Driver ageing does not cause higher accident rates per km. Transportation Research Part F, Traffic Psychol Behav 2002; 5: 271-274.
120. Lyman JM, McGwin G Jr, Sims RV. Factors related to driving difficulty and habits in older drivers. AccidAnal Prev 2001; 33: 413-421.
121. Verster JC. Measurement of the effects of psychoactive drugs on driving ability and related psychological processes. Utrecht, The Netherlands, 2002.
122. Alford C, Verster JC. NICE'review - not nice for patients! J Psychopharmacol 2005; 19: 19: 29-132.
123. Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev 2004; 8: 309-325.
124. Verster JC,Veldhuijzen DS, Patat A, Olivier B, Volkerts ER. Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Safety 2006; 1 (1): 63-72.
125. Hemmelgarn B, Suissa S, Huang A, et al. Benzodiazepint use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278: 27-31.
126. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in eldeily drivers. Am J Epidemiol 1992; 136: 873-883.
127. Leveille SG, Buchner DK Koepsell TD, et al. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 1994; 5: 591-598.
128. Dolder C, Nelson M, McKinsey J. Use of non-benzodiazepine hypnotics in elderly: are all agents the same? CNS Drugs 2007; 21: 389-405.
129. Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother 2006; 4: 169-192.
130. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep foundation Survey. Sleep 1999; 22:-22(Suppl 2): S347-S353.